Clinical Trials on Refractory Triple-Negative Breast Carcinoma
Total 2726 results
-
UNC Lineberger Comprehensive Cancer CenterMerck Sharp & Dohme LLCCompletedTriple Negative Breast CancerUnited States
-
West German Study GroupCelgeneActive, not recruiting
-
PharmAbcineActive, not recruitingTriple Negative Breast CancerAustralia
-
Canadian Cancer Trials GroupUniversity Health Network, Toronto; AstraZenecaActive, not recruitingBreast CancerCanada
-
Fudan UniversityCompleted
-
The Netherlands Cancer InstituteBristol-Myers SquibbActive, not recruitingBreast CancerNetherlands
-
Georgetown UniversityBristol-Myers SquibbActive, not recruitingTriple Negative Breast CancerUnited States
-
University of Wisconsin, MadisonThe V Foundation for Cancer ResearchTerminatedTriple Negative Breast CancerUnited States
-
Abbisko Therapeutics Co, LtdEnrolling by invitationTriple Negative Breast CancerChina
-
Baylor Research InstituteCompletedTriple Negative Breast CancerUnited States
-
The Methodist Hospital Research InstituteBristol-Myers SquibbCompleted
-
Cedars-Sinai Medical CenterAstraZenecaWithdrawnBreast Cancer | Triple Negative Breast CancerUnited States
-
University of Wisconsin, MadisonAvon FoundationTerminatedBreast Cancer | Triple Negative Breast CancerUnited States
-
ImmunityBio, Inc.Withdrawn
-
Cancer Institute and Hospital, Chinese Academy...Completed
-
Sun Yat-sen UniversityTerminatedTriple Negative Breast CancerChina
-
UNC Lineberger Comprehensive Cancer CenterNational Cancer Institute (NCI); GlaxoSmithKline; Susan G. Komen Breast Cancer...CompletedBreast CancerUnited States
-
AZ-VUBUniversitaire Ziekenhuizen KU Leuven; Universitair Ziekenhuis BrusselCompleted
-
Massachusetts General HospitalNational Cancer Institute (NCI); Federal Share CoreWithdrawnBreast CancerUnited States
-
Ottawa Hospital Research InstituteCompleted
-
Cancer Institute and Hospital, Chinese Academy...Unknown
-
PfizerAstellas Pharma Inc; Medivation, Inc.Withdrawn
-
Genentech, Inc.SOLTI Breast Cancer Research GroupCompletedBreast CancerUnited States, Spain, Portugal
-
Mario Negri Institute for Pharmacological ResearchTerminatedTriple Negative Breast CancerSpain, Italy, Portugal
-
Puma Biotechnology, Inc.CompletedBreast CancerSpain, United Kingdom, France, United States, Denmark, Hong Kong
-
Instituto Nacional de Cancer, BrazilCompletedTriple Negative Breast Cancer | Triple Negative Breast NeoplasmsBrazil
-
Clinica Universidad de Navarra, Universidad de...Unknown
-
CASI Pharmaceuticals, Inc.University of Colorado, Denver; Indiana University Melvin and Bren Simon Cancer...CompletedTriple Negative Breast CancerUnited States, China
-
China Breast Cancer Clinical Study GroupUnknown
-
SanofiBreast Cancer Research FoundationCompletedTriple Negative Breast CancerUnited States
-
Russian Academy of Medical SciencesRussian Society of Clinical OncologyUnknownTriple Negative Breast Cancer
-
Fudan UniversityUnknown
-
Thomas Jefferson UniversityUnknownBreast CancerUnited States
-
Nippon Kayaku Co., Ltd.CompletedTriple Negative Breast CancerUnited States
-
Severance HospitalUnknown
-
Baylor Breast Care CenterM.D. Anderson Cancer CenterTerminatedBreast CancerUnited States
-
M.D. Anderson Cancer CenterNational Institutes of Health (NIH)Withdrawn
-
Curis, Inc.CompletedHigh-grade Serous Ovarian Cancer | Solid Tumors | Triple-Negative Breast Cancer | NUT Midline CarcinomaUnited States
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced, Androgen Receptor Positive Triple Negative Breast CancerUnited States, Spain, Belgium, Canada, Ireland, United Kingdom, Italy
-
University Hospital, GrenobleRecruitingRadiation Therapy, Breast Cancer, Sequential Partial Breast Irradiation | Intermediate and High-risk Luminal and Triple Negative Breast CancerFrance
-
PfizerCompletedNeoplasmUnited States, Spain, Canada, Italy, United Kingdom
-
National Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI)CompletedStage IV Breast Cancer | Recurrent Breast Carcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Triple-Negative Breast CarcinomaUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.Active, not recruitingTriple Negative Breast Cancer | Invasive Breast Cancer | Stage IV Breast Cancer | HER2 NegativeUnited States
-
Oslo University HospitalKarolinska Institutet; Hoffmann-La Roche; Rigshospitalet, Denmark; Helse Stavanger... and other collaboratorsCompletedTriple Negative Breast Cancer | Cancer, BreastNorway, Denmark
-
Gilead SciencesRecruitingTriple Negative Breast Cancer | PD-L1 NegativeUnited States, Hong Kong, Belgium, Australia, Austria, Israel, Spain, Korea, Republic of, Taiwan, China, Japan, Netherlands, Brazil, Canada, Turkey, France, Germany, Malaysia, United Kingdom, Singapore, Hungary, Mexico, Italy, Switzer... and more
-
The First Affiliated Hospital with Nanjing Medical...Jiangsu HengRui Medicine Co., Ltd.RecruitingTNBC - Triple-Negative Breast CancerChina
-
Stephen ShiaoMerck Sharp & Dohme LLC; Incyte CorporationRecruitingBreast Cancer | TNBC - Triple-Negative Breast CancerUnited States
-
Zhenzhen LiuRecruitingBreast Cancer | Triple Negative Breast Cancer | CamrelizumabChina
-
Xijing HospitalRoche Pharma AGUnknownBreast Cancer | Triple Negative Breast Cancer | CapecitabineChina